🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

5/5 thx for this int initiative supported by numerous institutions in particular the following twitter users Luca Antonelli Praful Ravi DrBagrodia Sia Daneshmand, M.D. Patrizia Giannatempo Ragheed Saoud Scott Eggener Kathleen Olson, MD Natacha Naoun Nabil Adra Clint Cary Christopher Sweeney, MBBS

🦠 🦠 🦠 infectious complications are common after cystectomy. We reviewed the prevalence and potential preventive actions in the ERAS® Society cystectomy guideline panel 👁️Great research niche as antibiotics influence microbiome and response to immuno? sciencedirect.com/science/articl…

💪Stronger together! Kudos to Luca Antonelli Christian D. Fankhauser for leading this challenging collaborative project. Check out the thread below for more details 👇

We are finally on Twitter. 🎉 Here is the newest working group! We are happy to start our new projects and tackling new challenges in penile and testis cancer. Follow us to stay up-to-date. EAU Young Academics European Association of Urology (EAU) European School of Urology (EAU ESU) European Society of Residents in Urology

Today is International HPV Awareness Day — a day to emphasise the importance of screenings and vaccination agains HPV. 🧪💉 #penilecancer #hpv #urology

Today we had a chance to meet up and discuss future projects - great brainstorming session! #EAU23 #YAU

Low teratoma rate in primary RPLND for Stage IIa NSGCT with negative STM presented at #EAU23 summary by Luca Antonelli A0758 data from @SWENOTECA with 4% teratoma and 74% viable cancer in RPLND specimen. 98% RFS and CSS, 95% OS. Clavien-Dindo >2 post-op complications in 11%.

Need for organ preservation in pc-RPLND for advanced NSGCT at #EAU23 summary by Luca Antonelli A0759 Resected organs: 22% viable cancer, 39% teratoma, 39% necrosis -> need frozen sections! 22% Clavien-Dindo III-IV post-op complications. ↓ RFS in men with viable cancer or teratoma

Surveillance vs pcRPLND for metastatic NSGCT with intermediate/poor IGCCCG? Check it out at #AUA23 Christian D. Fankhauser YAU Working Group Penile & Testis Cancer

Pein in the surgical margins increases the risk of local recurrence of penile cancer🚨 what comes next? Closer monitoring? Adjuvant treatment? Nice discussion at #AUA23 Christian D. Fankhauser YAU Working Group Penile & Testis Cancer

🚨 our bladder neck/vesicourethral anastomosis technique led to promising continence - 91% no pads at all at 1y - early continence (median loss of 23g/24h only the day after catheter revmoval nice video and openAccess, Luca Antonelli Luca Afferi Agostino Mattei

Surgery in Motion: Anterior Sphincter-sparing Suturing of the Vesicourethral Anastomosis During Robotic-assisted Laparoscopic Radical Prostatectomy buff.ly/3P8CKQD Luca Antonelli Luca Afferi Agostino Mattei Christian D. Fankhauser #openscience #openaccess

📢 Exciting update from our latest analysis, published in the Journal of Clinical Oncology How to treat men with vital residuals in the pcRPLND specimen? MORE chemo or only follow-up? 👇 ascopubs.org/doi/abs/10.120… 🧵

Congratulations Luca Antonelli for leading this collaborative work, highlighting as always the need of an experienced multidisciplinary team for mGCTs management.

🌟An incredible day at the YAU meeting in #EMUC23 Marseille! 🤝🗣️ Exciting opportunity to connect and discuss our ongoing and future projects in an interdisciplinary way. #YAU #EMUCMarseille #Collaboration #Penilecancer #Testicularcancer European Association of Urology (EAU)

Incidence of VTEs during neoadjuvant chemotherapy for bladder cancer is high 🚨jim catto meetings.asco.org/abstracts-pres… Check out our poster at ASCO #GU24 supporting the role of thromboprophylaxis 💉 Christian D. Fankhauser

FREE fulltext paper link below: When I started performing radical cystectomies, I always struggled with how to stop and restart anticoagulation perioperatively. 🙄 😮 I then asked myself why this is such a common clinical scenario. I realized that many cystectomy patients

primary RPLND in CSIIa/b germ cell tumours+-adjuvant chemotherapy in >300 men, largest cohort published 📊 1/3 had no cancer in removed nodes, cave overtreatment 🎯 Larger marker neg nodes predict teratoma, resection in selected 2b 💉 2 cycles adj chemo after surgery at max

🎅Excited to share our latest research on #ERAS in #RadicalCystectomy, now published in European Journal of Surgical Oncology. We critically revisit perioperative care patterns integrating recent surgical advances. Honored to work with Simone Albisinni, Marco Moschini and a stellar panel of urologic surgeons

Cancer Statistics 2025 are out! #prostatecancer incidence still on the rise, mortality basically flat. Get screened so you can get treatment _when needed_. #pcsm acsjournals.onlinelibrary.wiley.com/doi/epdf/10.33…